|
(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol |
|
CHEBI:231000 |
|
This entity has been manually annotated by a third party.
|
|
MetaboLights
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C27H48O5/c1-17(2)7-6-8-18(3)21-9-10-22-20-15-24(31-29)27(32-30)16-19(28)11-14-26(27,5)23(20)12-13-25(21,22)4/h17-24,28-30H,6-16H2,1-5H3 |
YPRHNHJVGXHPES-UHFFFAOYSA-N |
O(O)C12C(C3C(C4C(C(CC4)C(CCCC(C)C)C)(CC3)C)CC1OO)(CCC(O)C2)C |
|
Outgoing
|
(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
(CHEBI:231000)
is a
cholestanoid
(CHEBI:50401)
|
|
5,6-dihydroperoxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
|
|